In the news: Outbound investment picks up in the US and GSK executives likely to be charged
November 07, 2013 | BY
clpstaff &clp articlesOutbound investment into the US reached record levels, boosted in part by the closing of Shuanghui's acquisition of Smithfield. GSK's executives under investigation are likely to be charged but the company may avoid penalties
Share:
China FDI reaches new heights in the US
Rhodium Group released their Chinese FDI in the United States: Q3 2013 Update last week. Shuanghui International's $7.1 billion acquisition of Smithfield marked the largest Chinese acquisition in the US